UNICA IRIS Institutional Research Information System

BALBONI, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 155.867
NA - Nord America 14.557
AS - Asia 5.791
SA - Sud America 908
Continente sconosciuto - Info sul continente non disponibili 594
AF - Africa 136
OC - Oceania 25
Totale 177.878
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 152.495
US - Stati Uniti d'America 14.358
SG - Singapore 2.295
CN - Cina 1.883
UA - Ucraina 981
BR - Brasile 703
SE - Svezia 670
VN - Vietnam 494
GB - Regno Unito 429
FI - Finlandia 405
FR - Francia 305
DE - Germania 303
HK - Hong Kong 297
IN - India 196
KR - Corea 125
CA - Canada 103
BD - Bangladesh 94
AR - Argentina 71
RU - Federazione Russa 71
IQ - Iraq 51
MX - Messico 46
JP - Giappone 40
ID - Indonesia 36
NL - Olanda 36
PK - Pakistan 33
CO - Colombia 32
ES - Italia 32
VE - Venezuela 32
MA - Marocco 31
EC - Ecuador 29
TR - Turchia 29
AT - Austria 25
BE - Belgio 23
ZA - Sudafrica 22
UZ - Uzbekistan 21
AU - Australia 20
PH - Filippine 20
PL - Polonia 20
SA - Arabia Saudita 20
KH - Cambogia 18
IL - Israele 17
CL - Cile 16
JO - Giordania 15
NP - Nepal 14
KE - Kenya 13
KZ - Kazakistan 13
EG - Egitto 12
IE - Irlanda 12
JM - Giamaica 12
MU - Mauritius 12
MY - Malesia 12
TN - Tunisia 11
DZ - Algeria 10
PE - Perù 10
AZ - Azerbaigian 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
LB - Libano 8
PY - Paraguay 8
TH - Thailandia 8
CR - Costa Rica 7
LT - Lituania 7
HU - Ungheria 6
NG - Nigeria 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
GT - Guatemala 5
PS - Palestinian Territory 5
SN - Senegal 5
KG - Kirghizistan 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
RS - Serbia 4
TW - Taiwan 4
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
IR - Iran 2
KW - Kuwait 2
LK - Sri Lanka 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 177.261
Salva come PNG Salva come JPEG
Città #
Cagliari 145.987
Uta 5.881
Fairfield 1.226
Singapore 1.182
Ashburn 1.165
Houston 1.043
Woodbridge 1.039
Chandler 978
San Jose 755
Boardman 739
Dallas 660
Ann Arbor 538
Wilmington 523
Jacksonville 521
Seattle 502
Cambridge 465
Nyköping 353
Council Bluffs 328
Beijing 267
Los Angeles 264
Hong Kong 250
Hefei 232
Helsinki 231
Nanjing 187
Boston 180
Lauterbourg 168
Santa Clara 166
The Dalles 160
Dearborn 132
Ho Chi Minh City 131
Buffalo 125
Seoul 117
Hanoi 108
San Diego 103
Columbus 93
Shanghai 92
Milan 90
Dong Ket 66
New York 58
Nanchang 57
Mountain View 56
Shenyang 56
Verona 53
Redwood City 52
Rome 50
Jiaxing 49
London 49
Tianjin 49
Chicago 46
Guangzhou 46
São Paulo 46
Ferrara 45
Washington 44
Changsha 40
Pune 40
Frankfurt am Main 39
Hebei 38
Falls Church 35
Norwalk 34
Toronto 32
Phoenix 28
Sassari 28
Tokyo 28
Paris 27
Jinan 26
Orange 26
Orem 26
Brooklyn 24
Redondo Beach 24
Ningbo 21
Saint Petersburg 21
Atlanta 20
Belo Horizonte 20
Mexico City 20
San Francisco 20
Tashkent 20
Baghdad 19
Rio de Janeiro 19
Nuremberg 18
Phnom Penh 18
Haiphong 17
Olbia 17
Brussels 16
Munich 16
Canberra 15
Zhengzhou 15
Amman 14
Casablanca 14
Jakarta 14
Chennai 13
Denver 13
Hyderabad 13
Lahore 13
Naples 13
Tappahannock 13
Warsaw 13
Auburn Hills 12
Brasília 12
Da Nang 12
Hangzhou 12
Totale 168.791
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and evaluation of antiproliferative activity of new benzimidazolehydrazones 2.925
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.869
Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors 2.847
Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain 2.813
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.738
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.717
TRPV1 modulators: synthesis and in vitro evaluation of 1-heteroarylpiperidinecarboxamide and piperazinylurea derivatives 2.673
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.605
DIHYDROQUINAZOLINE BENZYLAMIDES AS ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITORS 2.604
DESIGN, SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NEW DNA METHYLTRANSFERASE INHIBITORS 2.590
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives 2.532
Attenuating Ischemic Disruption of K+ Homeostasis in the Cortex of Hypoxic-Ischemic Neonatal Rats: DOR Activation vs. Acupuncture Treatment 2.484
Critical role for prokineticin 2 in CNS autoimmunity 2.469
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.371
3,4-Dihydroquinazoline derivatives inhibit the activities of cholinesterase enzymes 2.314
Benzofuran hydrazones as potential scaffold in the development of multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity 2.293
Indole derivatives as multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indole hydrazones 2.277
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.252
Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy 2.215
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation 2.211
Antagonism of EG-VEGF receptors as targeted therapy for choriocarcinoma progression in vitro and in vivo 2.105
Synthesis and evaluation of antioxidant and antiproliferative activity of 2-arylbenzimidazoles 2.081
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy 2.068
Synthesis and SIRT1 modulation studies of amides and hydrazides of benzoic acid incorporating a (2-trifluoromethylpyridin-4-yl)amino moiety 2.053
In-Vitro Evaluation of Antioxidant, Antiproliferative and Photo-Protective Activities of Benzimidazolehydrazone Derivatives 2.015
Interaction and reactivity of synthetic aminoisoflavones with metal-free and metalassociated amyloid-beta 1.910
PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice 1.870
An important role for prokineticin 2 in autoimmune CNS demyelination 1.821
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties 1.794
Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors 1.779
null 1.768
δ-Opioid Receptor Activation Attenuates Hypoxia/MPP+-Induced Downregulation of PINK1: a Novel Mechanism of Neuroprotection Against Parkinsonian Injury 1.655
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 1.643
Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease 1.591
Genetically Encodable Bacterial Flavin Transferase for Fluorogenic Protein Modification in Mammalian Cells 1.585
Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated 1.559
Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors 1.536
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity 1.486
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 1.465
Prokineticin 2 promotes and sustains neuroinflammation in vincristine treated mice: Focus on pain and emotional like behavior 1.404
null 1.383
Antagonism of EG-VEGF receptors is a novel targeted therapy for choriocarcinoma progression: in vitro, in vivo and in clinical studies 1.375
A novel mechanism for cytoprotection against hypoxic injury: delta-opioid receptor-mediated increase in Nrf2 translocation 1.359
Ligand- and cell-dependent determinants and cAMP modulation by delta opioid receptor (DOR) agonists 1.357
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins 1.352
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors 1.338
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system 1.289
The antagonism of the prokineticin system counteracts bortezomib induced side effects: Focus on mood alterations 1.282
Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes 1.268
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context 1.245
Prokineticin 1-prokineticin receptor 1 signaling promotes angiogenesis in the porcine endometrium during pregnancy 1.176
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain 1.167
∂-opioid receptor activation protects against Parkinson’s disease-related mitochondrial dysfunction by enhancing PINK1/Parkin-dependent mitophagy 1.157
Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals 1.102
Opposite Roles of δ- and μ-Opioid Receptors in BACE1 Regulation and Alzheimer’s Injury 1.095
Evidence-Based View of Safety and Effectiveness of Prokineticin Receptors Antagonists during Pregnancy 1.055
Antidepressant-like and anxiolytic-like effects following activation of the mu-delta opioid receptor heteromer in the nucleus accumbens 959
Synthesis and Carbonic Anhydrase Inhibitory Activity of New 2-Aminochromenone Derivatives 913
δ‐Opioid receptors up‐regulate excitatory amino acid transporters in mouse astrocytes 882
Delta-opioid receptor activation modified microRNA expression in the rat kidney under prolonged hypoxia 873
Effect of delta-opioid receptor activation on BDNF-TrkB vs. TNF-Alpha in the mouse cortex exposed to prolonged hypoxia 867
activation of the mu-delta opioid receptor heteromer produces anti-depressant-like and anxiolytic-like effects 852
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 846
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain 834
null 825
New features of the delta opioid receptor: conformationalproperties of deltorphin I analogues 820
Prokineticin receptors antagonist PC-10 as a biomarker for imaging inflammatory pain 818
Agonists at the delta-opioid receptor modify the binding of mu-receptor agonists to the mu-delta receptor hetero-oligomer 816
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 811
Hair Growth Promotion by δ-Opioid Receptor Activation 782
Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis 745
Blocking prokineticin receptors attenuates synovitis and joint destruction in collagen-induced arthritis 736
Conformational dynamics of KIR3.1/KIR3.2 channel activation via delta-opioid receptors (DORs) 735
Structural and biological exploration of Phe3-Phe4-modified endomorphin-2 peptidomimetics 733
null 731
Ligands raise the constraint that limits constitutive activation in G protein-coupled opioid receptors 730
Hydrogen sulfide inhibits inflammatory pain and enhances the analgesic properties of delta opioid receptors 711
Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity 691
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues. 690
DOR activation inhibits anoxic/ischemic Na+ influx through Na+ channels via PKC mechanisms in the cortex 685
Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore 664
Na+ mechanism of delta-opioid receptor induced protection from K+ leakage in the cortex 642
Role of the 2',6'-dimethyl-L-tyrosine (Dmt) in some opioid lead compounds 640
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues 639
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist, correlation between desensitization and tolerance 637
Prokineticin System Is a Pharmacological Target to Counteract Pain and Its Comorbid Mood Alterations in an Osteoarthritis Murine Model 635
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 632
Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors 619
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain 612
Structure-activity relatioships of tetrapeptides related to dermorphin: a 500-MHz 1H-nmr study 587
A Critical Role of δ-Opioid Receptor in Anti-microglial Activation Under Stress 583
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore 569
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 564
Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice 563
Hydrogen Sulfide Increases the Analgesic Effects of µ- and δ-Opioid Receptors during Neuropathic Pain: Pathways Implicated 561
Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism 550
null 546
Prokineticin 1 is a novel factor regulating porcine corpus luteum function 539
Synthesis of N-FmocN,N'-bis-Boc-5-,6- and 8-guanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid (5-GTIC, 6-GTIC and 8-GTIC) 538
Opioid peptides. Synthesis and binding properties of dermorphin related heptapeptides 537
Totale 136.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 262.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 262.607
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.946 0 806 1.092 529 420 819 912 643 595 587 934 1.609
2022/202316.522 1.658 1.741 1.164 1.262 1.464 2.157 1.168 1.527 978 1.019 1.601 783
2023/202419.214 725 818 712 1.288 1.898 3.050 3.230 1.222 924 1.297 1.763 2.287
2024/202539.798 8.850 11.727 5.060 4.256 2.362 2.242 3.438 216 421 314 361 551
2025/202610.356 606 578 1.421 759 666 648 1.493 818 936 1.656 629 146
2026/2027752 360 392 0 0 0 0 0 0 0 0 0 0
Totale 177.878